RSV vaccine enters Phase 1 clinical trials
by Press Release from Outbreak News Today on (#2DKM7)
A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial also will assess the vaccine's ability to prompt an immune response in healthy adult participants. The investigational vaccine was developed ["]
The post RSV vaccine enters Phase 1 clinical trials appeared first on Outbreak News Today.